JBJI - Home

Editor-in-chief: Derek Amanatullah & Fintan Moriarty

eISSN: 2206-3552

The Journal of Bone and Joint Infection (JBJI), as a scientific publication of the European Bone and Joint Infection Society (EBJIS) and MusculoSkeletal Infection Society (MSIS), publishes papers of highest quality in all areas of orthopaedic infections. Types of articles include research papers, short research communications, reviews, case reports, and letters.

News

03 Dec 2025 New MS Word template available for manuscript preparation

The existing MS Word template for authors has been significantly expanded and now includes many important notes on the standard sections that must be included in the manuscript. Please visit the "Submission" page, section "Templates for your manuscript file" and download the new template before writing your next manuscript.

03 Dec 2025 New MS Word template available for manuscript preparation

The existing MS Word template for authors has been significantly expanded and now includes many important notes on the standard sections that must be included in the manuscript. Please visit the "Submission" page, section "Templates for your manuscript file" and download the new template before writing your next manuscript.

13 Mar 2025 Get involved, become a referee, and help shape JBJI's community publication output

We are pleased to announce that a new referee application form is now available. This means that if you are interested in contributing to the peer-review process and supporting high-quality scientific publishing in your community then you can apply today to become a referee. Your expertise can make a difference. Visit the online form here to learn more and join our reviewer community.

13 Mar 2025 Get involved, become a referee, and help shape JBJI's community publication output

We are pleased to announce that a new referee application form is now available. This means that if you are interested in contributing to the peer-review process and supporting high-quality scientific publishing in your community then you can apply today to become a referee. Your expertise can make a difference. Visit the online form here to learn more and join our reviewer community.

05 Feb 2025 Copernicus Publications and all journals left Twitter

The Copernicus Twitter account as well as all Twitter accounts of journals published by us have been deactivated. There will be no automatic feeds of newly posted preprints or published journal articles anymore, we do not actively tweet, and the status informs that the accounts are no longer maintained. Twitter is no longer linked from the journal websites or in the share section of the preprint or journal article HTML pages.

05 Feb 2025 Copernicus Publications and all journals left Twitter

The Copernicus Twitter account as well as all Twitter accounts of journals published by us have been deactivated. There will be no automatic feeds of newly posted preprints or published journal articles anymore, we do not actively tweet, and the status informs that the accounts are no longer maintained. Twitter is no longer linked from the journal websites or in the share section of the preprint or journal article HTML pages.

News archive

Notice on the current situation in Ukraine

To show our support for Ukraine, all fees for papers from authors (first or corresponding authors) affiliated to Ukrainian institutions are automatically waived, regardless if these papers are co-authored by scientists affiliated to Russian and/or Belarusian institutions. The only exception will be if the corresponding author or first contact (contractual partner of Copernicus) are from a Russian and/or Belarusian institution, in that case the APCs are not waived.

In accordance with current European restrictions, Copernicus Publications does not step into business relations with and issue APC-invoices (articles processing charges) to Russian and Belarusian institutions. The peer-review process and scientific exchange of our journals including preprint posting is not affected. However, these restrictions require that the first contact (contractual partner of Copernicus) has an affiliation and invoice address outside Russia or Belarus.